Table 2. Characterization of the glioblastoma-derived cell primary cultures used in this study.
| Primary cultures | MGMT/18s | MGMT protein | MGMT methylation | miR200a/U6 | TMZ IC50, μM |
|---|---|---|---|---|---|
| GBM.4 | 0.21 ± 0.08 [2 105] * | + | M | 1.1 10−2 ± 1.6 10−2 | >300 |
| GBM.5 | 7.0 10−3 ± 0.8 10−3 [5 103] | + | M | 0.11 ± 0.51 | >300 |
| GBM.7 | 2.5 10−3 ± 0.7 10−3 [2.5 103] | + | UM | 0.53 | >300 |
| GBM.8 | 5.0 10−3 ± 1.1 10−3 [5 103] | +/− | M | >300 | |
| GBM.9 | 2.1 10−4 ± 1.0 10−4 [2 102] | nd | M | 1.12 ± 0.22 | 250 |
| GBM.10 | 0.9 10−4 ± 0.3 10−4 [0.9 102] | nd | M | 250 | |
| GBM.11 | 2.3 10−4 ± 0.9 10−4 [2.3 102] | nd | M | 0.12 | 220 |
| GBM.12 | 0.83 ± 0.03 [8 105] | ++ | UM | 3.0 10−3 ± 0.6 10−3 | >300 |
| GBM.14 | 7.0 10−3 ± 2.3 10−2 [7 103] | UM | 0.4 ± 2.1 10−2 | 220 | |
| GBM.15 | 0.80 ± 0.05 [8 105] | ++ | UM | 1.33 10−3 ± 0.11 10−3 | >300 |
| GBM.16 | 5.0 10−2 ± 0.11 [5 104] | ++ | UM | 1.50 10−2 ± 0.07 10−2 | 220 |
| GBM.19 | 2.3 10−3 ± 0.6 10−3 [2.3 103] | UM | 1.9 10−2 ± 0.7 10−3 | >300 | |
| GBM.21 | 3.0 10−3 ± 0.9 10−4 [3 103] | ++ | UM | 6.8 10−2 ± 0.8 10−2 | >300 |
| GBM.22 | 1.8 10−2 ± 1.0 10−4 [1.8 104] | ++ | UM | 7.3 10−3 ± 1.6 10−3 | >300 |
| GBM.23 | 0.12 ± 0.05 [1.2 105] | ++ | UM | >300 | |
| GBM.24 | 1.9 10−3 ± 1.3 10−3 [1.9 103] | M | 1.5 10−2 ± 2.1 10−2 | >300 | |
| GBM.25 | 2.0 10−6 ± 0.3 10−6 [2] | nd | M | 1.64 ± 0.11 | 180 |
*in brackets, relative expression level of MGMT, taking MGMT level in U87 cells as 1 (cf Table 1); nd, no detectable; M, methylated MGMT; UM, unmethylated MGMT.